Updated: January 11, 2026
What Is Mycophenolic Acid? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
What is mycophenolic acid (Myfortic, CellCept)? A complete patient guide to uses, dosage forms, how to take it, and important safety information for 2026.
If you've recently had a kidney, heart, or liver transplant—or if you've been diagnosed with an autoimmune condition—you may have been prescribed mycophenolic acid. But what exactly is it, how does it work, how do you take it, and what do you need to know to stay safe? This guide answers all of those questions in plain language.
What Is Mycophenolic Acid?
Mycophenolic acid (MPA) is an immunosuppressant medication—a drug that weakens your immune system to prevent it from attacking something it shouldn't. It belongs to a class called selective immunosuppressants and antimetabolites, and it is the active compound in two widely used medications:
Myfortic — the brand name for mycophenolate sodium (the sodium salt of MPA), an enteric-coated delayed-release tablet
CellCept — the brand name for mycophenolate mofetil (a prodrug that converts to MPA in the body), available as capsules, tablets, oral suspension, and IV formulation
Both deliver mycophenolic acid to your body, but through different pathways and with different absorption timing. They are not interchangeable without physician oversight.
Mycophenolic acid was initially discovered by Italian scientist Bartolomeo Gosio in 1893 as a compound with antibacterial properties. Its immunosuppressive properties were identified in the 1990s, and it was approved for medical use in the United States in 1995—making it a well-established medication with decades of real-world safety data.
What Is Mycophenolic Acid Used For?
FDA-Approved Uses:
Prevention of kidney transplant rejection (adults and children 5+ years for Myfortic; 3+ months for CellCept)
Prevention of heart transplant rejection (CellCept only)
Prevention of liver transplant rejection (CellCept only)
Common Off-Label Uses:
Lupus nephritis (kidney inflammation from lupus)
IgA nephropathy
Small vessel vasculitis
Pemphigus vulgaris and bullous pemphigoid (blistering skin disorders)
Crohn's disease and inflammatory bowel disease
Pulmonary fibrosis (interstitial lung disease)
Available Dosage Forms and Strengths
Myfortic (mycophenolate sodium):
Delayed-release tablets: 180 mg and 360 mg
Swallow whole—do not crush, cut, or chew
Can be taken with or without food (enteric coating protects the stomach)
CellCept (mycophenolate mofetil):
Capsules: 250 mg
Tablets: 500 mg (film-coated, do not crush)
Oral suspension: 200 mg/mL (ready-to-use with Myhibbin brand, or powder for reconstitution)
IV injection: 500 mg/vial (hospital use)
Typically taken on an empty stomach (1 hour before or 2 hours after meals)
Typical Dosage
Myfortic for kidney transplant (adults): 720 mg twice daily (total 1,440 mg/day)
CellCept for kidney transplant (adults): 1,000 mg twice daily (total 2,000 mg/day)
CellCept for heart or liver transplant (adults): 1,500 mg twice daily (total 3,000 mg/day)
Your actual dose may differ based on your specific situation, kidney function, concomitant medications (particularly whether you're on cyclosporine or tacrolimus), and your physician's assessment. Never adjust your dose without guidance from your transplant team.
Key Things to Know When Taking Mycophenolic Acid
Do not use during pregnancy: This medication carries an FDA boxed warning for embryofetal toxicity. Use two reliable forms of contraception while taking it and for 6 weeks after stopping.
Avoid live vaccines: Do not receive live virus vaccines (such as MMR, varicella, yellow fever) while taking mycophenolate.
Regular lab monitoring: Your doctor will monitor your blood counts (CBC) and kidney function regularly while you are on this medication.
Sun protection: Wear SPF 30+ sunscreen and protective clothing when outdoors to reduce skin cancer risk.
Want to understand how mycophenolic acid works at a molecular level? Read How Does Mycophenolic Acid Work?. And if your pharmacy is ever out of stock, medfinder can help you locate it quickly.
Frequently Asked Questions
Mycophenolic acid (Myfortic) is FDA-approved for the prevention of organ rejection after kidney transplantation in adults and children 5 years and older. Its prodrug form, mycophenolate mofetil (CellCept), is additionally approved for heart and liver transplants. Both are also widely used off-label for autoimmune conditions including lupus nephritis, vasculitis, pemphigus vulgaris, and pulmonary fibrosis.
Myfortic (mycophenolate sodium) is an enteric-coated delayed-release tablet that releases in the intestine, while CellCept (mycophenolate mofetil) is a prodrug that is absorbed in the stomach and converted to mycophenolic acid in the body. Both deliver the same active compound, but they have different absorption rates, dosing equivalents, and FDA-approved indications. They are not interchangeable without physician supervision.
Myfortic (mycophenolate sodium) is available as enteric-coated delayed-release tablets in two strengths: 180 mg and 360 mg. The standard adult dose for kidney transplant rejection prevention is 720 mg (two 360 mg tablets or four 180 mg tablets) taken twice daily, for a total daily dose of 1,440 mg. This is equivalent to CellCept 1,000 mg twice daily on a molar basis.
Most transplant patients take mycophenolic acid for life. The immune system continues to recognize the transplanted organ as foreign throughout the recipient's lifetime, requiring ongoing immunosuppression to prevent rejection. While some stable, long-term patients may have their doses reduced under physician guidance, stopping mycophenolate entirely without medical direction poses significant risk of rejection.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Mycophenolic Acid also looked for:
More about Mycophenolic Acid
31,889 have already found their meds with Medfinder.
Start your search today.





